DANANG PHARMACEUTICAL MEDICAL EQUIP — Gliclazide Importer Profile
Pharmaceutical Importer · #2 buyer for Gliclazide · $1.1M import value · 24 shipments · VIETNAM, DEMOCRATIC REP. OF · DGFT Verified
DANANG PHARMACEUTICAL MEDICAL EQUIP is the #2 importer of Gliclazide from India with $1.1M in import value and 24 verified shipments. DANANG PHARMACEUTICAL MEDICAL EQUIP holds a 0.6% market share in Gliclazide imports based in VIETNAM, DEMOCRATIC REP. OF. The company sources from 1 verified supplier across 19 formulations shipped to 3 countries.
DANANG PHARMACEUTICAL MEDICAL EQUIP — Gliclazide Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Gliclazide to DANANG PHARMACEUTICAL MEDICAL EQUIP?
Verified from 24 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| PANACEA BIOTEC PHARMA LIMITED | $1.1M | 24 | 100.0% |
DANANG PHARMACEUTICAL MEDICAL EQUIP sources Gliclazide from 1 verified Indian supplier based on 24 customs records. The primary supplier is PANACEA BIOTEC PHARMA LIMITED accounting for 100.0% of imports.
How Does DANANG PHARMACEUTICAL MEDICAL EQUIP Compare to Nearest Gliclazide Importers?
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 15 | CRESCENT PHARMA LIMITED | UNITED KINGDOM | $1.2M | 54 | $22.2K |
| 1 | MYLAN HUNGARY KFT, | HUNGARY | $1.1M | 21 | $50.0K |
| 2 | DANANG PHARMACEUTICAL MEDICAL EQUIP ★ | VIETNAM | $1.1M | 21 | $50.0K |
| 5 | DELTA IMPORT EXPORT MEDICAL CO., LT | VIETNAM | $600.0K | 12 | $50.0K |
| 13 | SOHACO TRADING AND PHARMACEUTICAL | VIETNAM | $550.0K | 11 | $50.0K |
DANANG PHARMACEUTICAL MEDICAL EQUIP ranks #2 among 643 Gliclazide importers from India. Average shipment value of $50.0K compared to the market average of $40.7K. The closest competitors by value are CRESCENT PHARMA LIMITED and MYLAN HUNGARY KFT,.
Where Does DANANG PHARMACEUTICAL MEDICAL EQUIP Import Gliclazide To?
Destination countries from 24 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| VIETNAM, DEMOCRATIC REP. OF | $759.7K | 17 | 68.5% |
| VIETNAM DEMOCRATIC REP. OF | $200.0K | 4 | 18.0% |
| VIETNAM | $150.0K | 3 | 13.5% |
DANANG PHARMACEUTICAL MEDICAL EQUIP imports Gliclazide to 3 countries. The primary destination is VIETNAM, DEMOCRATIC REP. OF receiving 68.5% of shipments worth $759.7K.
What Gliclazide Formulations Does DANANG PHARMACEUTICAL MEDICAL EQUIP Import?
| Formulation | Value | Shipments |
|---|---|---|
| GLIZYM M TABLETS (EACH UNCOATED TABLET CONTAINS GLICLAZIDE BP 80 MG + METFORMINHYDROCHLORIDE IP 500 MG) B/N.18423044 TO | $137.8K | 3 |
| GLIZYM M TABLETS EACH UNCOATED TABLET CONTAINS GLICLAZIDE BP 80 MG + METFORMINHYDROCHLORIDE IP 500 MG B/N.18423020 TO | $100.0K | 2 |
| GLIZYM M TABLETS (EACH UNCOATED TABLET CONTAINS GLICLAZIDE BP 80 MG + METFORMINHYDROCHLORIDE IP 500 MG) B/N.18423035 TONOS | $71.8K | 3 |
| GLIZYM M TABLETS EACH UNCOATED TABLET CONTAINS GLICLAZIDE BP 80 MG + METFORMINHYDROCHLORIDE IP 500 MG B/N.18423017, 1 | $50.0K | 1 |
| GLIZYM M TABLETS (EACH UNCOATED TABLET CONTAINS GLICLAZIDE BP 80 MG + METFORMINHYDROCHLORIDE IP 500 MG) B/N.18423023 TO | $50.0K | 1 |
| GLIZYM M TABLETS (EACH UNCOATED TABLET CONTAINS GLICLAZIDE BP 80 MG + METFORMINHYDROCHLORIDE IP 500 MG) B/N.18423026 TO | $50.0K | 1 |
| GLIZYM M TABLETS (EACH UNCOATED TABLET CONTAINS GLICLAZIDE BP 80 MG + METFORMINHYDROCHLORIDE IP 500 MG) B/N.18423038 M/ | $50.0K | 1 |
| GLIZYM-M TABLETS (EACH UNCOATED TABLETCONTAINS GLICLAZIDE BP 80MG+METFORMIN HYDROCHLORIDE IP 500MG)( B/NO: 18424014 TO | $50.0K | 1 |
| GLIZYM-M TABLETS (EACH UNCOATED TABLETCONTAINS GLICLAZIDE BP 80MG+METFORMIN HYDROCHLORIDE IP 500MG) B/NO:18424008 TO 1 | $50.0K | 1 |
| GLIZYM-M TABLETS (EACH UNCOATED TABLETCONTAINS GLICLAZIDE BP 80MG+METFORMIN HYDROCHLORIDE IP 500MG)( B/NO: 18424017 TO | $50.0K | 1 |
DANANG PHARMACEUTICAL MEDICAL EQUIP imports 19 distinct Gliclazide formulations from India. The top formulation is GLIZYM M TABLETS (EACH UNCOATED TABLET CONTAINS GLICLAZIDE B with 3 shipments worth $137.8K.
Who Are the Top Buyers of Gliclazide from India and How Much Does DANANG PHARMACEUTICAL MEDICAL EQUIP Import?
India exported $26.2M worth of Gliclazide through 3,830 shipments from 238 suppliers to 109 countries, serving 643 buyers globally. DANANG PHARMACEUTICAL MEDICAL EQUIP imports $1.1M of this total, accounting for 0.6% of India's Gliclazide exports with 24 shipments from VIETNAM, DEMOCRATIC REP. OF. This is verified from 24 customs shipment records covering 19 distinct formulations.
What Is the Average Order Value for DANANG PHARMACEUTICAL MEDICAL EQUIP's Gliclazide Imports?
DANANG PHARMACEUTICAL MEDICAL EQUIP's average Gliclazide order value is $46.2K per consignment, based on 24 shipments totaling $1.1M. DANANG PHARMACEUTICAL MEDICAL EQUIP is based in VIETNAM, DEMOCRATIC REP. OF and ranks #2 among all Gliclazide importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Gliclazide to DANANG PHARMACEUTICAL MEDICAL EQUIP?
DANANG PHARMACEUTICAL MEDICAL EQUIP sources Gliclazide from 1 verified Indian supplier: PANACEA BIOTEC PHARMA LIMITED ($1.1M, 100.0%). This is based on 24 customs records.
How Does DANANG PHARMACEUTICAL MEDICAL EQUIP Compare to Other Gliclazide Importers?
DANANG PHARMACEUTICAL MEDICAL EQUIP ranks #2 among 643 Gliclazide importers from India with a 0.6% market share. The top 3 importers are TORRENT DO BRASIL LTDA ($6.5M), MEDREICH PLC ($3.1M), M/S. RANBAXY FARMACEUTICA LTDA : ($2.4M). DANANG PHARMACEUTICAL MEDICAL EQUIP processed 24 shipments from VIETNAM, DEMOCRATIC REP. OF.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Gliclazide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Gliclazide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: DANANG PHARMACEUTICAL MEDICAL EQUIP matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as DANANG PHARMACEUTICAL MEDICAL EQUIP's capped import value divided by total capped export value for Gliclazide across all Indian exporters.
- 5.Verified Records: This page is backed by 24 individual customs records matching DANANG PHARMACEUTICAL MEDICAL EQUIP importing Gliclazide, covering 19 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 643+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Gliclazide Import Data for DANANG PHARMACEUTICAL MEDICAL EQUIP
Access order-level details, pricing data, supplier connections, and competitive analysis for DANANG PHARMACEUTICAL MEDICAL EQUIP's Gliclazide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
DANANG PHARMACEUTICAL MEDICAL EQUIP
Company Profile
Multiple products · $0 total trade · Multiple categories
DANANG PHARMACEUTICAL MEDICAL EQUIP × Gliclazide
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for DANANG PHARMACEUTICAL MEDICAL EQUIP.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Gliclazide. For current order-level data, contact TransData Nexus.